Home> Latest

Hangzhou and Italian firms explore biopharmaceutical cooperation opportunities

Hangzhoufeel| Updated: November 11, 2026 L M S

HZ81_副本.jpg

HZ82_副本.jpg

HZ83_副本.jpg

HZ84_副本.jpg

From Nov 3 to 4, the China-Italy (Hangzhou) Biopharmaceutical Industry Innovation Cooperation Matchmaking Event, hosted by the Hangzhou Investment Promotion Bureau, was held in Hangzhou. A delegation of more than 20 Italian biopharmaceutical companies, industry associations, and industry service agencies attended the event and held face-to-face discussions with over 20 Hangzhou-based enterprises and institutions, including Betta Pharmaceuticals, Hangzhou Alltest Biotech, and Heda Fund.

An important stop of the visit was Hangzhou Pharma Town. The park is home to more than 1,800 pharmaceutical companies, including seven global leading pharmaceutical companies such as Pfizer.

During the matchmaking discussions, "partner" became the most frequently used word among the Italian side, which places the greatest value on local teams that understand the Chinese market. At the conclusion of the event, the two sides signed a series of cooperation agreements.

1 2 3 4